原发性经尿道膀胱肿瘤电切术中即刻评估逼尿肌状态的荧光共聚焦显微镜可行性研究
这项前瞻性、盲法、配对队列可行性研究纳入34例疑似非肌层浸润性膀胱癌行原发性TURBT的患者,术中行离体荧光共聚焦显微镜(FCM)成像评估逼尿肌(DM)状态,以病理为金标准。FCM在全部30例可评估标本中均成功判读,特异性100%但敏感性仅42%,阴性预测值21%,诊断用时5.4分钟远快于病理的11天。FCM可行且特异性高,但低敏感性和低阴性预测值限制其单独用于术中排除DM。
要点
- FCM可在术中快速成像TURBT标本,中位5.4分钟确认逼尿肌状态,病理需11天。
- FCM检测逼尿肌特异性100%、敏感性42%,阴性预测值仅21%。
- FCM不宜作为独立工具术中排除逼尿肌,不应在研究外指导术中决策。
核心结论
- FCM对TURBT标本术中快速成像可行,检测逼尿肌特异性极好,但低敏感性和低阴性预测值使其不能单独用于术中排除逼尿肌。
- 基于此,FCM不应在研究环境之外指导术中决策。
研究设计与样本
- 前瞻性、盲法、配对队列可行性研究(IB1-LaserComplete,ISRCTN16114765),2024年9月至2025年9月连续纳入原发性TURBT疑似非肌层浸润性膀胱癌患者。
- 共招募34例,30例有可评估配对标本;术中离体FCM成像肿瘤基底标本,盲法泌尿病理医生和泌尿外科医生判读,以甲醛固定组织病理为参考标准。
主要发现
- 逼尿肌缺失见于13%(30例中4例)。
- FCM在所有患者中足以判定逼尿肌状态(100%,30/30)。
- 敏感性42%(95%CI 26-61%),特异性100%(95%CI 51-100%),阳性预测值100%(95%CI 74-100%),阴性预测值21%(95%CI 9-43%)。
- 泌尿病理医生与泌尿外科医生观察者间一致性高,为83%(κ=0.72,95%CI 0.47-0.97)。
- 确认逼尿肌状态的中位时间FCM为5.4(四分位距4.95-5.39)分钟,标准病理为11(7-13.8)天。
关键数值与推荐
- 主要结局技术可行性定义为获得可判读的FCM图像,本研究中所有可评估患者均达到(100%)。
- 次要结局包括探索性诊断性能、观察者间一致性和确认逼尿肌状态的时间。
临床怎么用
- FCM可在术中快速提供逼尿肌状态信息,特异性高,但敏感性低,不能单独用于排除逼尿肌。
- 基于当前证据,FCM不应在研究环境外指导术中决策。
局限性
- 可行性研究样本量小(30例可评估),诊断性能为探索性次要结局。
- 逼尿肌缺失比例低(13%),可能影响阴性预测值的稳定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate ex vivo fluorescence confocal microscopy (FCM) for immediate detrusor muscle (DM) assessment during primary transurethral resection of bladder tumour (TURBT). PATIENTS AND METHODS: This prospective, blinded, paired-cohort feasibility study enrolled consecutive patients undergoing primary TURBT for suspected non-muscle-invasive bladder cancer between September 2024 and September 2025 (IB1-LaserComplete study; International Standard Randomised Controlled Trial Number Register [ISRCTN]16114765). Ex vivo FCM generates immediate high-resolution digital images of fresh tissue, enabling immediate DM assessment. Intraoperative ex vivo FCM imaging of en face tumour base specimens was performed using the Histolog® scanner (SamanTree Medical SA, Lausanne, Switzerland). DM status was reported by a blinded uro-pathologist and urologist. Formalin-fixed histopathology served as the reference standard. The primary outcome was technical feasibility, defined as acquisition of an interpretable FCM image. Secondary outcomes included exploratory diagnostic performance, inter-observer agreement and time to confirmation of DM status. RESULTS: A total of 34 patients were recruited and 30 had evaluable paired specimens. DM was absent in 13% (four of 30). FCM was sufficient for determining DM status in all patients (100%; 30 of 30). Sensitivity, specificity, positive predictive value, negative predictive value (NPV) were 42% (95% confidence interval [CI] 26-61%), 100% (95% CI 51-100%), 100% (95% CI 74-100%), and 21% (95% CI 9-43%), respectively. Inter-observer agreement between the uro-pathologist and urologist was high at 83% (κ = 0.72, 95% CI 0.47-0.97). The median (interquartile range) time to confirm DM status was 5.4 (4.95-5.39) min vs 11 (7-13.8) days using standard histopathology. CONCLUSION: Fluorescence confocal microscopy is feasible for rapid intraoperative imaging of TURBT specimens and demonstrates excellent specificity for detection of DM. However, its low sensitivity and NPV preclude use as a stand-alone tool to exclude DM intraoperatively. Based on these findings, FCM should not guide intraoperative decision making outside research settings.
引用
- Connor MJ, Gopalakrishnan A, Mayor N, et al. Immediate intraoperative detrusor muscle status at primary transurethral resection of bladder tumour: a prospective, blinded, paired cohort, feasibility study using fluorescence confocal microscopy (IB1-LaserComplete study). BJU Int. 2026. PMID: 42596073. doi:10.1111/bju.70395
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。